These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6090273)

  • 1. Differential rate of age-related decline in immune functions in genetically defined mice with different tumor incidence and life span.
    Hirokawa K; Utsuyama M; Goto H; Kuramoto K
    Gerontology; 1984; 30(4):223-33. PubMed ID: 6090273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses in newly developed short-lived SAM mice. I. Age-associated early decline in immune activities of cultured spleen cells.
    Hosokawa T; Hosono M; Higuchi K; Aoike A; Kawai K; Takeda T
    Immunology; 1987 Nov; 62(3):419-23. PubMed ID: 3499380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Background pathology in BDF1 mice allowed to live out their life-span.
    Yamate J; Tajima M; Kudow S; Sannai S
    Lab Anim; 1990 Oct; 24(4):332-40. PubMed ID: 2270043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of age-associated immune decline and mortality by early repeated administration of bestatin to C57BL/6 mice.
    Bruley-Rosset M; Payelle B; Rappaport H
    J Biol Response Mod; 1986 Apr; 5(2):176-90. PubMed ID: 3488372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dietary 2-mercaptoethanol on the life span, immune system, tumor incidence and lipid peroxidation damage in spleen lymphocytes of aging BC3F1 mice.
    Heidrick ML; Hendricks LC; Cook DE
    Mech Ageing Dev; 1984 Oct; 27(3):341-58. PubMed ID: 6334792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dietary restriction of varying duration on survival, tumor patterns, immune function, and body temperature in B10C3F1 female mice.
    Cheney KE; Liu RK; Smith GS; Meredith PJ; Mickey MR; Walford RL
    J Gerontol; 1983 Jul; 38(4):420-30. PubMed ID: 6306089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Age-related incidence of spontaneous tumors in SPF C57BL/6 and BDF1 mice].
    Nakamura K; Kuramoto K; Shibasaki K; Shumiya S; Ohtsubo K
    Jikken Dobutsu; 1992 Jul; 41(3):279-85. PubMed ID: 1324182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
    Yamasaki T; Moritake K; Klein G
    J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic control of immune responsiveness, aging and tumor incidence.
    Doria G; Biozzi G; Mouton D; Covelli V
    Mech Ageing Dev; 1997 Jun; 96(1-3):1-13. PubMed ID: 9223107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inheritance of immune responsiveness, life span, and disease incidence in interline crosses of mice selected for high or low multispecific antibody production.
    Covelli V; Mouton D; Di Majo V; Bouthillier Y; Bangrazi C; Mevel JC; Rebessi S; Doria G; Biozzi G
    J Immunol; 1989 Feb; 142(4):1224-34. PubMed ID: 2915118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of host antitumor defense mechanisms in mice by progressively growing tumor.
    Maccubbin DL; Mace KF; Ehrke MJ; Mihich E
    Cancer Res; 1989 Aug; 49(15):4216-24. PubMed ID: 2525950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-span, tumor incidence, and natural killer cell activity in mice selected for high or low antibody responsiveness.
    Covelli V; Marini S; Di Majo V; Bassani B; Mancini C; Adorini L; Doria G
    J Natl Cancer Inst; 1984 May; 72(5):1127-36. PubMed ID: 6585589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte function and life span in a murine model of premature immunosenescence.
    Guayerbas N; Puerto M; Víctor VM; Miquel J; De la Fuente M
    Exp Gerontol; 2002; 37(2-3):249-56. PubMed ID: 11772510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cytotoxic lymphocytes obtained by in vitro immunization with syngeneic lymphoma cells on pluripotent hemopoietic cells].
    Voĭtenok NN; Mitskevich PB; Murzenok PP
    Biull Eksp Biol Med; 1985 May; 99(5):604-6. PubMed ID: 3873966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin deficiency suppresses lymphoma growth in mice by modulating NK cells, CD8 T cells, and myeloid-derived suppressor cells.
    Han S; Jeong AL; Lee S; Park JS; Kim KD; Choi I; Yoon SR; Lee MS; Lim JS; Han SH; Yoon DY; Yang Y
    J Immunol; 2013 May; 190(9):4877-86. PubMed ID: 23530146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
    Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma.
    Ho RL; Maccubbin DL; Ujházy P; Zaleskis G; Eppolito C; Mihich E; Ehrke MJ
    Oncol Res; 1993; 5(9):363-72. PubMed ID: 8038457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dietary restriction and aging on natural killer cell activity in mice.
    Weindruch R; Devens BH; Raff HV; Walford RL
    J Immunol; 1983 Feb; 130(2):993-6. PubMed ID: 6600261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.